Evidence map›Paper›PMID 39767558›Full record

ArticleBiomedicines2024

Reference Interval for Glycated Albumin, 1,5-AG/GA, and GA/HbA1c Ratios and Cut-Off Values for Type 1, Type 2, and Gestational Diabetes: A Cross-Sectional Study.

Yusra Al-Lahham, Waldemar Volanski, Liana Signorini, Ademir Luiz do Prado, Glaucio Valdameri, Vivian Rotuno Moure, Marciane Welter, Alexessander C Alves, Marcel Henrique Marcondes Sari, Fabiane Gomes de Moraes Rego and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Yusra Al-LahhamGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-0506-1852
Waldemar VolanskiGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Liana SignoriniGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Ademir Luiz do PradoGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-9914-3831
Glaucio ValdameriGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-1882-1512
Vivian Rotuno MoureGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-0968-8190
Marciane WelterGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.
Alexessander C AlvesSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Marcel Henrique Marcondes SariGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0002-9913-9306
Fabiane Gomes de Moraes RegoGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.ORCID 0000-0003-1726-8524
Geraldo PichethGraduate Program in Pharmaceutical Sciences, Federal University of Paraná, Curitiba 80210-170, Brazil.

Funding

CNPq project no. 407034/2023-4
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1,5-anhydroglucitoldiabetesglycated albuminglycated hemoglobinglycemic biomarkersglycemic control

Identifiers

PMID39767558
PMCPMC11673511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.